Petco Health & Wellness Company, Inc. (WOOF) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-08-01..
Quick ratio
Overview →Financial period ending 2026-08-01; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-08-01. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 1.17B USD | Liabilities, Current |
| Cash and equivalents | 293.50M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 38.39M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 601.59M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-08-01 | (m) | $1.17B | $293.50M | (m) | $38.39M | $601.59M | (m) |
| 2026-05-02 | (m) | $1.13B | $166.80M | (m) | $36.93M | $632.91M | (m) |
| 2026-01-31 | (m) | $1.13B | $256.74M | (m) | $45.81M | $590.21M | (m) |
| 2025-11-01 | (m) | $1.10B | $237.41M | (m) | $42.90M | $617.90M | (m) |
| 2025-08-02 | (m) | $1.06B | $188.75M | (m) | $34.52M | $608.51M | (m) |
| 2025-05-03 | (m) | $1.08B | $133.34M | (m) | $36.08M | $645.47M | (m) |
| 2025-02-01 | (m) | $1.14B | $165.76M | (m) | $40.42M | $653.33M | (m) |
| 2024-11-02 | (m) | $1.11B | $116.67M | (m) | $40.43M | $690.29M | (m) |
| 2024-08-03 | (m) | $1.12B | $127.62M | (m) | $47.03M | $672.33M | (m) |
| 2024-05-04 | (m) | $1.07B | $89.72M | (m) | $42.08M | $681.02M | (m) |
| 2024-02-03 | (m) | $1.11B | $125.43M | (m) | $44.37M | $684.50M | (m) |
| 2023-10-28 | (m) | $1.11B | $139.78M | (m) | $50.18M | $730.15M | (m) |
| 2023-07-29 | (m) | $1.07B | $173.01M | (m) | $66.26M | $675.44M | (m) |
| 2023-04-29 | (m) | $996.89M | $148.94M | (m) | $45.41M | $667.94M | (m) |
| 2023-01-28 | (m) | $1.02B | $201.90M | (m) | $49.58M | $652.43M | (m) |
| 2022-10-29 | (m) | $1.06B | $148.73M | (m) | $46.45M | $723.42M | (m) |
| 2022-07-30 | (m) | $1.04B | $125.19M | (m) | $44.76M | $723.34M | (m) |
| 2022-04-30 | (m) | $1.01B | $190.89M | (m) | $42.22M | $682.04M | (m) |
| 2022-01-29 | (m) | $1.05B | $211.60M | (m) | $55.62M | $675.11M | (m) |
| 2021-10-30 | (m) | $1.03B | $221.48M | (m) | $45.48M | $644.39M | (m) |
| 2021-07-31 | (m) | $1.01B | $203.40M | (m) | $39.89M | $628.49M | (m) |
| 2021-05-01 | (m) | $995.18M | $174.03M | (m) | $38.08M | $574.68M | (m) |
| 2021-01-30 | (m) | $875.31M | $111.40M | (m) | $41.83M | $538.67M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.